Amends TCA Title 4; Title 53; Title 56; Title 68 and Title 71.

Tennessee SB0436 amends various sections of the Tennessee Code Annotated to allow the bureau of TennCare to implement cost-saving measures for pharmaceutical services that include the use of biosimilars. The bill affects health carriers, health benefit plans, and the TennCare pharmacy advisory committee by permitting them to require patients to try biosimilars before covering branded drugs and mandating the use of biosimilars in certain prescription programs. Key provisions include the inclusion of biosimilars in step therapy protocols, the authority to mandate their use for the uninsured, and the requirement for the pharmacy advisory committee to consider biosimilars in their recommendations.